Endocrine oncology

The Relationship Between Hospital Safety-Net Burden on Outcomes for High-Volume Thyroid Cancer Surgeons

ThyroidPublished Retrospective cohort study

Authors' conclusion

The performance of HV thyroid cancer surgeons differs by a hospital's safety-net burden, with patients treated at high safety-net burden hospitals experiencing higher rates of operative complications, disease-specific mortality, and all-cause mortality.

Study context

Population
Patients who underwent surgery for thyroid cancer in California, 1999–2017; High-volume (HV) surgeons (annual case volume ≥10) performing total thyroidectomy; 78% female, median age 5013,848 treated by HV surgeons
Participants
42,347 patients
Exposure
HV surgeons at Q4 vs Q1 hospitals
Outcome
Perioperative and oncologic outcomes of HV surgeons across safety-net burden quartiles
Methodological detailspopulation-based (California), mixed-effects regression model
  • Population-based (California)
  • Mixed-effects regression model

Main finding

As reported in the abstract

Absolute risk, Q4 vs Q1 (multivariable analysis)
Q4
absolute risk difference, endocrine complications +7%; P = 0.007
Q4
absolute risk difference, airway complications +6%; P = 0.004
Q4
absolute risk difference, disease-specific mortality +1.3%; P = 0.046
Q4
absolute risk difference, all-cause mortality during study period +3%; P = 0.046

Observational data: associations, not effects.

Further findings

Characteristics of patients of HV vs lower-volume surgeons

Patients of HV surgeons more likely White, upper socioeconomic quartiles and well insured
all p < 0.001
HV surgeons in each safety-net burden quartile displayed similar case number distributions

Original publication

The Relationship Between Hospital Safety-Net Burden on Outcomes for High-Volume Thyroid Cancer Surgeons. Thyroid. Published 11 November 2024. doi:10.1089/thy.2024.0268

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.